Seven classes of antiviral agents

A Ianevski, S Ahmad, K Anunnitipat… - Cellular and Molecular …, 2022 - Springer
The viral epidemics and pandemics have stimulated the development of known and the
discovery of novel antiviral agents. About a hundred mono-and combination antiviral drugs …

Emerging roles of SnoRNAs in the pathogenesis and treatment of autoimmune disorders

G Dubey, M Singh, H Singh, M Agarwal… - … -Research and Practice, 2023 - Elsevier
SnoRNAs (small non-coding RNAs) have recently gained prominence in autoimmune
diseases, revealing their crucial role in modulating the immune response and contributing to …

Introduction to Epigenetics

N Singla, R Thapa, R Kulshrestha, AA Bhat… - Targeting Epigenetics in …, 2023 - Springer
Epigenetics is the study of inherited variations in gene expression that do not involve
changes to DNA sequences. Over 200 unique cell types in a human adult have a nearly …

[HTML][HTML] Nanomaterials-assisted gene editing and synthetic biology for optimizing the treatment of pulmonary diseases

L Lei, W Pan, X Shou, Y Shao, S Ye… - Journal of …, 2024 - ncbi.nlm.nih.gov
The use of nanomaterials in gene editing and synthetic biology has emerged as a pivotal
strategy in the pursuit of refined treatment methodologies for pulmonary disorders. This …

[HTML][HTML] CRISPR-Cas12b enables a highly efficient attack on HIV proviral DNA in T cell cultures

M Fan, Y Bao, B Berkhout, E Herrera-Carrillo - Biomedicine & …, 2023 - Elsevier
Abstract Background The novel endonuclease Cas12b was engineered for targeted
genome editing in mammalian cells and is a promising tool for certain applications because …

Bridging autoimmunity and epigenetics: The influence of lncRNA MALAT1

S Mohan, MA Hakami, HG Dailah, A Khalid… - … -Research and Practice, 2024 - Elsevier
Autoimmune disorders represent a heterogeneous spectrum of conditions defined by an
immune system's atypical reactivity against endogenous constituents. In the complex …

HIV epidemiology, prevention, treatment, and implementation strategies for public health

A Mody, AH Sohn, C Iwuji, RKJ Tan, F Venter, EH Geng - The Lancet, 2024 - thelancet.com
The global HIV response has made tremendous progress but is entering a new phase with
additional challenges. Scientific innovations have led to multiple safe, effective, and durable …

[HTML][HTML] Targeted disruption of the BCR-ABL fusion gene by Cas9/dual-sgRNA inhibits proliferation and induces apoptosis in chronic myeloid leukemia cells: Cas9 …

J Zeng, X Liang, L Duan, F Tan, L Chen… - Acta Biochimica et …, 2024 - ncbi.nlm.nih.gov
The BCR-ABL fusion gene, formed by the fusion of the breakpoint cluster region protein
(BCR) and the Abl Oncogene 1, Receptor Tyrosine Kinase (ABL) genes, encodes the BCR …

Application of CRISPR–Cas Technology in Drug Development

S Altaf, F Saleem, HM Ikram, A Iftikhar… - Trends in Plant …, 2024 - Springer
The discovery of clustered regularly interspaced short palindromic repeat (CRISPR)-Cas
technology has transformed the science of genome editing, providing exemplary accuracy …

CRISPR and gene editing in HIV therapy: A scoping review

E Tuta-Quintero, CM Ayala, MÁM Ardila… - Gaceta Médica de …, 2023 - saber.ucv.ve
Human immunodeficiency virus (HIV) is nowadays one of the major health problems
worldwide. Several strategies have been explored for the eradication of latent HIV-1 …